ROARABLE
Today ⌘ Pro Terminal Big Ideas 🎲 Predictions Screener πŸ¦‹ Butterfly 8 Analysts πŸ›οΈ Policy 🎬 Video β˜… Watchlist 🎲 Prediction Markets πŸ“Š RQD Track Record πŸ“… Next Catalysts πŸ›‘οΈ Overlap & Crash X-Ray πŸ“° Live Wire πŸ‹ 13F Whales πŸ›οΈ Congress & CEO Buys πŸ† $100K Arena ⌘ Pro Terminal πŸ“ Methodology & Corrections
Stock Ratings / Health Care / BFLY / dividends
PHG (58) GEHC (65) NNOX (22) VIR (43) ⌘ Pro Terminal β†’

Butterfly Network Inc. (Class A) (BFLY) Dividend Safety Gauge & 10-Year DRIP Compounder

$6.39 -14.91% NYSE β€’ Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $6.21

Butterfly Network Inc. (Class A) (BFLY) carries a Roarable Rating of D (Sell) with 45/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

πŸ“Š Historical Track Record Warning: Scores below 50 (45/100 Β· D) historically underperformed SPY in 71% of rolling 90-day windows β†’
ROARABLE D β€’ SELL / AVOID Cap $2.00B
πŸ“€ Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚑ INSTANT AI QUANT PREVIEW β€’ $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on BFLY Below β€” or Connect Your Own ChatGPT / Claude
πŸ€– Mara Quenwick β€’ AI Quant Lead (Click for Instant Brief) Is BFLY stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
β–Ό

As of 2026-11-02, Butterfly Network Inc. (Class A) (NYSE: BFLY) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 45/100 at a spot price of $6.39 (-14.91% 1D, market cap $2.00B). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 14/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, BFLY ranks #400 in composite RQD confidence.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Ellis Vennor β€’ AI Peer & Flow Quant (Click for Instant Brief) How does BFLY compare to PHG and GEHC in the Health Care sector?
β–Ό

Within the Health Care sector (Medical Electronics), BFLY carries a Roarable D (45/100 RQD), trailing P/E of N/A, gross margin of 46.9%, and ROIC of -35.0%. By comparison, PHG (Koninklijke Philips N.V. NY Registry Shares) holds a D+ grade (58/100 RQD, P/E 32.8x, ROIC 9.9%, cap $26.66B) and GEHC (GE HealthCare Technologies Inc.) posts a C grade (65/100 RQD, P/E 16.6x, ROIC 14.2%, cap $34.55B). Among the 5-stock peer group, GEHC leads on earnings multiple (16.6x) while GEHC leads on capital efficiency (14.2% ROIC).

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Gideon Ashmere β€’ AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for BFLY?
β–Ό

Per BFLY's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001804176), Butterfly Network Inc. (Class A) generated $97.6M in revenue (+19.0% YoY), -$77.1M in net income, and -$16.0M in free cash flow against $296.5M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists β€” not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
πŸ›‘οΈ Portfolio Crash X-Ray
EXT / AFTER-HRS: $6.21 (-2.87%)🧬 Dilution Drag (+2.48% YoY Shares)βš™οΈ Cash Engine: 10/20 (D) β€’ 0% FCF Margin
Verify 90D Bucket Audit β†’
πŸ“Š Historical Track Record Warning: Scores below 50 (45/100 Β· D) historically underperformed SPY in 71% of rolling 90-day windows (-6.3% avg 90D alpha vs SPY β€’ 29.0% hit rate).
Audit Bucket Track Record β†’
RQD QUANT TACHOMETERSELL / AVOID β€’ D
025507510045
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) β€” not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- Β· Rk D+
Cash (10)Whales (11)SEC (14)Macro (7)CEO (3)
Each axis scored 0–20
12M PRICE TARGET CONE-5.8% Base Target
$11 Bull$6 Base$5 Bear
πŸ“¬ FREE BFLY RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: β€” (No Active Options Snapshot on file for BFLY)Realized 20D OHLCV Swing Band: Β±12.5%
Deterministic 5-Pillar Attribution (45/100 Composite)
πŸ” WHY BFLY SCORES 45/100 (D) β€” TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
β–² #1 Bullish Driver: SEC 10-K Forensic Risk+14/20 pts (31% of score)

Altman Z-Score 7.89 (FORTRESS SAFE (>3.0)) β€’ Piotroski F-Score 4/9

β–² #2 Bullish Driver: Whale & Options Positioning+11/20 pts (24% of score)

20D Institutional Volume Accumulation (Β±12.5% realized swing band)

β–Ό #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

πŸ“ˆ PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 β†’ Q2 β†’ Q3 β†’ Current
Q1 (-3Q)
53
Grade C-$8.55-12.6% Next Q
Q2 (-2Q)
50
Grade C-$7.47-10.8% Next Q
Q3 (-1Q)
48
Grade D$6.66-4.1% Next Q
Current
45
Grade D$6.39-6.3% Hist 90D Ξ±
Trajectory: C- (53) β†’ D (45)Full Audit β†’
βš”οΈ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

βš”οΈ Adversarial Opposing Case: What Could Spark a BFLY Turnaround Squeeze

Gideon Ashmere Forensic Desk β†’

While BFLY currently carries a cautious 45/100 (D) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

πŸš€ Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

πŸš€ Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($8.03) and Max Pain ($6.71) forces dealer call-delta covering toward $10.72.

πŸš€ Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $BFLYβ€’ $2.4M Crowd Pool β€’ Kalshi / Polymarket Composite
Contract: β€œBFLY Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
YES 45%NO 55%Trade / Inspect Odds β†’
CASH DIVIDEND + BUYBACK YIELD
0.6% Total Yield
0% Cash ($0.00/yr) + 0.6% Buybacks
PAYOUT SAFETY SPEEDOMETER
74/100 β€’ REINVESTING IN GROWTH + BUYBACKS
FREE CASH FLOW PAYOUT RATIO
0% (100% Reinvested)
Retains cash flow for R&D and share repurchases
INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (11.1% EST. ANNUAL)

$10,000 Compounded Over 10 Years β†’ $28,651

Est. Year-10 Shareholder Yield: $172/yr
$11.1K
Yr 1
$12.3K
Yr 2
$13.7K
Yr 3
$15.2K
Yr 4
$16.9K
Yr 5
$18.8K
Yr 6
$20.9K
Yr 7
$23.2K
Yr 8
$25.8K
Yr 9
$28.7K
Yr 10
ON-DEMAND RQD QUANT WORKSHOP β€’ SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring BFLY)

  • βœ“Walkthrough of BFLY's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • βœ“3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • βœ“Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) β†’$100K Arena
BFLY // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +31.75%β–Ό SUPPORT BREAKDOWN
2026-11-02O $7.81H $7.81L $6.39C $6.39VOL 5.90M
RES: $10.29SUP: $7.59SMA50: $8.03SMA200: $6.06
$10.71$8.63$6.55$4.47$2.38RES $10.29SUP $7.59$6.392026-05-042026-06-172026-08-042026-09-172026-11-02
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

BFLY Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

πŸ¦‹ BFLY Butterfly Map β†’ + Track BFLY β†’
Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth

vs. +19.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on BFLY today. View full Setup Ledger β†’

πŸ¦‹ Documented & Second-Order Butterfly Connections Open Graph β†’

No direct multi-tier Butterfly edges indexed yet for BFLY. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for BFLY today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk β†’
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT β€’ SEC EDGAR XBRL Γ— RQD PEER BENCHMARK

πŸ“Š Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BFLY)

Health Care Rank #400 of 1016 βš”οΈ PHG vs BFLY Full Matrix β†’

1. Head-to-Head Health Care Peer Comparison (BFLY vs. PHG, GEHC, NNOX, VIR)

Industry: Medical Electronics (4 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Butterfly Network Inc. (Class A) (BFLY) ranks #400 by composite RQD confidence (45/100, grade D) and #265 by equity capitalization ($2.00B). Within this direct 5-issuer industry benchmark cohort, GEHC leads on earnings valuation at 16.6x trailing P/E, while GEHC leads on capital efficiency and profitability with 14.2% ROIC and 40.0% gross margin. GEHC currently holds the highest overall quantitative score in the immediate peer group at 65/100 (C) compared with BFLY at 45/100 (D).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
BFLY ACTIVE
Butterfly Network Inc. (Class A)
D 45/100 β€” 46.9% -35.0% -14.91% $2.00B Benchmark Subject
PHG
Koninklijke Philips N.V. NY Registry Shares
D+ 58/100 32.8x β€” 9.9% -0.74% $26.66B /phg-vs-bfly β†’
GEHC
GE HealthCare Technologies Inc.
C 65/100 16.6x 40.0% 14.2% +0.20% $34.55B /gehc-vs-bfly β†’
NNOX
NANO-X IMAGING LTD
E 22/100 β€” -30.0% -35.0% +7.95% $24.0M /nnox-vs-bfly β†’
VIR
Vir Biotechnology Inc.
D- 43/100 β€” 96.0% -35.0% -3.83% $2.01B /vir-vs-bfly β†’

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K β€’ FILED 2025-12-31 β€’ CIK 0001804176

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Butterfly Network Inc. (Class A) (BFLY) reported GAAP revenue of $97.6M (+19.0% vs. FY2024 revenue of $82.1M , and +48.1% cumulative change since FY2023) , GAAP net income of -$77.1M, operating cash flow of -$12.7M, and free cash flow of -$16.0M (+63.9% YoY). On the balance sheet, BFLY closed FY2025 with $296.5M in total assets against $0 in total debt (Altman Z-Score: 7.89, Piotroski F-Score: 4/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $97.6M -$77.1M -$12.7M -$16.0M $296.5M β€”
FY2024 (FY) 2024-12-31 $82.1M -$72.5M -$41.7M -$44.4M $256.1M β€”
FY2023 (FY) 2023-12-31 $65.9M -$133.7M -$98.8M -$98.8M β€” β€”

3. BFLY Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

βœ“ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is BFLY stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-02, Butterfly Network Inc. (Class A) (NYSE: BFLY) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 45/100 at a spot price of $6.39 (-14.91% 1D, market cap $2.00B). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 14/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, BFLY ranks #400 in composite RQD confidence.

How does BFLY compare to PHG and GEHC in the Health Care sector?

Within the Health Care sector (Medical Electronics), BFLY carries a Roarable D (45/100 RQD), trailing P/E of N/A, gross margin of 46.9%, and ROIC of -35.0%. By comparison, PHG (Koninklijke Philips N.V. NY Registry Shares) holds a D+ grade (58/100 RQD, P/E 32.8x, ROIC 9.9%, cap $26.66B) and GEHC (GE HealthCare Technologies Inc.) posts a C grade (65/100 RQD, P/E 16.6x, ROIC 14.2%, cap $34.55B). Among the 5-stock peer group, GEHC leads on earnings multiple (16.6x) while GEHC leads on capital efficiency (14.2% ROIC).

What are the biggest fundamental strengths and SEC risk factors for BFLY?

Per BFLY's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001804176), Butterfly Network Inc. (Class A) generated $97.6M in revenue (+19.0% YoY), -$77.1M in net income, and -$16.0M in free cash flow against $296.5M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is BFLY trading relative to its 50-day, 200-day, and 52-week technical levels?

BFLY last traded at $6.39 (-14.91% on volume of 7,481,011 shares), positioning the stock -20.42% below its 50-day simple moving average ($8.03) and +5.45% above its 200-day simple moving average ($6.06). Across its 52-week range of $1.90 to $10.21, BFLY sits at the 54.0% percentile with a 14-day RSI of 48.7 (NEUTRAL RANGE) and an implied next-earnings move of Β±12.5% ($5.59 to $7.19).

BFLY Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS β€’ SEC EDGAR Γ— CBOE Γ— FRED

Does BFLY pay a dividend and is it safe?

Butterfly Network Inc. (Class A) (BFLY) offers a 0% cash dividend yield ($0.00 annualized) and 0.6% total shareholder yield including buybacks. Roarable rates its payout coverage as REINVESTING IN GROWTH + BUYBACKS.

Direct Sub-Reports: BFLY RQD Cockpit BFLY 12M Forecast BFLY Earnings & Move BFLY Dividends & DRIP BFLY Insiders & 13F BFLY Whale Options BFLY Profit Sankey BFLY News & Why
ROARABLE RATING BRIEF β€’ RQD 45/100 (D) βœ“ STAGE-C NUMBER FIREWALL VERIFIED

BFLY β€” Butterfly Network Inc. (Class A): What the Facts Mean to a Prospective Investor

Engine: Haiku 5.5 Dossier Pipeline
As of: 2026-11-02T14:21Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD 5-pillar rating engine, Butterfly Network Inc. (Class A) (BFLY) carries a composite score of 45/100 (D β€” Roarable Sell β€” Underperform / Distribution Warning) at a current price of $6.39 (-14.91%). Fundamental cash generation scores 10/20 (ROIC -35.0%, FCF yield -0.80%), institutional 13F whale accumulation scores 11/20, insider conviction scores 3/20, macro regime alignment scores 7/20 (Beta 1.00), and forensic balance-sheet protection scores 14/20 (Altman Z-Score 7.89, Piotroski F-Score 4/9).

Investor Implication: At current trailing P/E and current forward P/E within Medical Electronics, upside depends on sustained operating margin expansion (-60.0%) and free cash flow conversion relative to the 52-week range of $1.90 – $10.21.

Butterfly Effect: Supply-Chain, Sector & Catalyst Ripples

Operating in Medical Electronics (Health Care), BFLY is sensitive to 2nd-order capital expenditure cycles, input cost spreads (gross margin 46.9%), and institutional positioning across its peer cohort. Prospective investors should monitor quarterly order backlog conversion, sector capex guidance, and Form 4 insider cluster activity (0 recent filings tracked).

Open Questions to Watch: (1) Margin trajectory vs. peer median; (2) FCF conversion sustainability over the next 4 quarters; (3) Institutional 13F rebalancing around upcoming earnings.

BFLY Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Butterfly Network Inc. (Class A) (BFLY) β€’ Click "Debate This Headline" to argue it in the Roar Pit below

πŸ’¬ Jump to BFLY Debate Forum (3) ↓
🟒 CATALYST Yahoo β€’ 3d ago
Butterfly Network Q3 Earnings Call Highlights

Butterfly Network (NYSE:BFLY) reported third-quarter 2026 revenue of $32.6 million, up 52% from a year earlier and 9% above the high end of its guidance range, as growth in its Embedded business and enterprise-focused po

Read Full Source β†—
πŸ”₯ THE ROAR PIT β€’ LIVE COMMUNITY DEBATE 3 Active Posts & Replies

BFLY Bull vs. Bear Conversation Board β€” What's Your Call at $6.39?

πŸ‚ 33% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON BFLY 🐻 67% BEARISH CONVICTION
1. Pick Your Side on BFLY:
πŸ’‘ Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
RO RoarDesk_Moderator Roarable Research Desk 🐻 BEARISH 🎯 Target: $6.61 (-12.0%)
πŸ“Œ Pinned Debate

πŸ”₯ Official Bull vs. Bear Debate: Is BFLY (D β€’ RQD 45/100) a Buy at $7.51?

Welcome to the BFLY (Butterfly Network Inc. (Class A)) Roar Pit. Current RQD Composite is 45/100 (Roarable Sell β€” Underperform / Distribution Warning) in Medical Electronics. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (πŸ‚ Bull or 🐻 Bear) and drop your price target below.

RI RiskArb_Desk Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $5.78 (-23.0%)
Spot @ $7.51

Pump the brakes on BFLY β€” check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on BFLY, but look at what you are paying: current EV/EBITDA multiples with 46.9% gross margins. Unless Butterfly Network Inc. (Class A) expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

CA CashFlowKing Verified K Arena Trader πŸ‚ BULLISH 🎯 Target: $9.09 (+21.0%)
Spot @ $7.51

BFLY cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on BFLY, the market is fixating on short-term headline noise in Medical Electronics and ignoring the balance sheet and cash flow trajectory. At $7.51 (52-wk range $1.90 - $10.21), any beat on forward guidance forces shorts and underweight funds to chase.

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.36 -0.94% GLD $355.78 -1.34%